{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Biochanin A", "MAPK signaling pathway", "Osteoclasts", "Oxidative stress", "Type 2 diabetic osteoporosis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38191438", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": ["24", "10.1186/s12906-023-04332-x"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "08"}], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "08"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation.", "Pagination": {"StartPage": "24", "MedlinePgn": "24"}, "Abstract": {"AbstractText": ["There are accumulating type 2 diabetes patients who have osteoporosis simultaneously. More effective therapeutic strategies should be discovered. Biochanin A (BCA) has been indicated that can play a role in improving metabolic disorders of type 2 diabetes and preventing osteoporosis. But whether BCA can treat type 2 diabetic osteoporosis has not been studied.", "To investigate if the BCA can protect against type 2 diabetic osteoporosis and clarify the mechanism.", "Micro-CT and histology assays were performed to detect the trabecular bone and analyze the bone histomorphology effect of BCA. CCK-8 assay was performed to detect the toxicity of BCA. TRAcP staining, immunofluorescence and hydroxyapatite resorption assay were used to observe osteoclasts differentiation and resorptive activity. Molecular docking provided evidence about BCA regulating the MAPK axis via prediction by the algorithm. QRT-PCR and Western Blotting were utilized to detect the expression of osteoclastogenesis-related markers and MAPK signaling pathway.", "Accumulation of bone volume after BCA treatment could be found based on the 3D reconstruction. Besides, there were fewer osteoclasts in db/db mice treated with BCA than db/db mice treated with saline. In vitro, we found that BCA hadn't toxicity in osteoclasts precursor, but also inhibited differentiation of osteoclasts. Further, we found that BCA suppresses osteoclastogenesis via ROS/MAPK signaling pathway.", "BCA can prevent type 2 diabetic osteoporosis by restricting osteoclast differentiation via ROS/MAPK signaling pathway."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "He", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "Fifth School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}], "LastName": "Yang", "ForeName": "Junzheng", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fifth School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}], "LastName": "Chen", "ForeName": "Weijian", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Pan", "ForeName": "Zhaofeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Chen", "ForeName": "Baihao", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Zeng", "ForeName": "Jiaxu", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, P.R. China."}], "LastName": "Zhang", "ForeName": "Nenling", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Lin", "ForeName": "Yuewei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Chen", "ForeName": "Chuyi", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Xiao", "ForeName": "Jiacong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Li", "ForeName": "Miao", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First School of Medicine, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China."}, {"Identifier": [], "Affiliation": "The Laboratory of Orthopaedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, P.R. China."}], "LastName": "Li", "ForeName": "Shaocong", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, First Affiliated Hospital, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China. hipknee@163.com."}], "LastName": "Wang", "ForeName": "Haibin", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, First Affiliated Hospital, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun Area, Guangzhou, 510405, P.R. China. docchen777@gmail.com."}], "LastName": "Chen", "ForeName": "Peng", "Initials": "P"}], "GrantList": [{"GrantID": "NO. 82074462", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "82374470", "Agency": "National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "U13J6U390T", "NameOfSubstance": "biochanin A"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Osteogenesis"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Mohsin S, et al. An update on therapies for the treatment of diabetes-induced osteoporosis. Expert Opin Biol Ther. 2019;19(9):937\u2013948. doi: 10.1080/14712598.2019.1618266.", "ArticleIdList": ["10.1080/14712598.2019.1618266", "31079501"]}, {"Citation": "Vestergaard V. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2013a meta-analysis. Osteoporos Int. 2007;18(4):427\u2013444. doi: 10.1007/s00198-006-0253-4.", "ArticleIdList": ["10.1007/s00198-006-0253-4", "17068657"]}, {"Citation": "Schacter GI, Leslie WD. Diabetes and osteoporosis: part II, Clinical Management. Endocrinol Metab Clin North Am. 2021;50(2):287\u2013297. doi: 10.1016/j.ecl.2021.03.006.", "ArticleIdList": ["10.1016/j.ecl.2021.03.006", "34023044"]}, {"Citation": "Tian S, et al. Modeling compound-target interaction network of traditional Chinese medicines for type II Diabetes Mellitus: insight for polypharmacology and drug design. J Chem Inf Model. 2013;53(7):1787\u20131803. doi: 10.1021/ci400146u.", "ArticleIdList": ["10.1021/ci400146u", "23768230"]}, {"Citation": "Cui X, et al. Scutellariae Radix and Coptidis Rhizoma improve glucose and lipid metabolism in T2DM rats via regulation of the metabolic profiling and MAPK/PI3K/Akt signaling pathway. Int J Mol Sci. 2018;19(11):3634. doi: 10.3390/ijms19113634.", "ArticleIdList": ["10.3390/ijms19113634", "PMC6274950", "30453687"]}, {"Citation": "Guo Q, et al. Study on hypoglycemic effect of the drug pair of Astragalus Radix and Dioscoreae Rhizoma in T2DM rats by Network Pharmacology and Metabonomics. Molecules. 2019;24(22):4050. doi: 10.3390/molecules24224050.", "ArticleIdList": ["10.3390/molecules24224050", "PMC6891682", "31717456"]}, {"Citation": "Sun L, et al. Additional benefit of Chinese Medicine Formulae Including Dioscoreae rhizome (Shanyao) for Diabetes Mellitus: current state of evidence. Front Endocrinol (Lausanne) 2020;11:553288. doi: 10.3389/fendo.2020.553288.", "ArticleIdList": ["10.3389/fendo.2020.553288", "PMC7685178", "33244311"]}, {"Citation": "Wang S, et al. A comprehensive review on Pueraria: insights on its chemistry and medicinal value. Biomed Pharmacother. 2020;131:110734. doi: 10.1016/j.biopha.2020.110734.", "ArticleIdList": ["10.1016/j.biopha.2020.110734", "32942158"]}, {"Citation": "Ma R, et al. Diabetic Osteoporosis: A Review of Its Traditional Chinese Medicinal Use and Clinical and Preclinical Research. Evid Based Complement Alternat Med. 2016;2016:3218313. doi: 10.1155/2016/3218313.", "ArticleIdList": ["10.1155/2016/3218313", "PMC5028800", "27698674"]}, {"Citation": "Oza MJ, Kulkarni YA. Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 Diabetes. Biomed Pharmacother. 2018;107:1119\u20131127. doi: 10.1016/j.biopha.2018.08.073.", "ArticleIdList": ["10.1016/j.biopha.2018.08.073", "30257324"]}, {"Citation": "Shen P, et al. Differential effects of isoflavones, from Astragalus Membranaceus and Pueraria Thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr. 2006;136(4):899\u2013905. doi: 10.1093/jn/136.4.899.", "ArticleIdList": ["10.1093/jn/136.4.899", "16549448"]}, {"Citation": "Tan JW, Kim MK. Neuroprotective effects of Biochanin a against \u03b2-Amyloid-Induced neurotoxicity in PC12 cells via a mitochondrial-dependent apoptosis pathway. Molecules. 2016;21(5):548. doi: 10.3390/molecules21050548.", "ArticleIdList": ["10.3390/molecules21050548", "PMC6274559", "27120593"]}, {"Citation": "Dubey RK, et al. 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension. 1998;31(1 Pt 2):522\u2013528. doi: 10.1161/01.HYP.31.1.522.", "ArticleIdList": ["10.1161/01.HYP.31.1.522", "9453356"]}, {"Citation": "Siddiqui MT, Siddiqi M. Hypolipidemic principles of Cicer arietinum: biochanin-A and formononetin. Lipids. 1976;11(3):243\u2013246. doi: 10.1007/BF02532865.", "ArticleIdList": ["10.1007/BF02532865", "177835"]}, {"Citation": "Harini R, Ezhumalai M, Pugalendi KV. Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. Eur J Pharmacol. 2012;676(1\u20133):89\u201394. doi: 10.1016/j.ejphar.2011.11.051.", "ArticleIdList": ["10.1016/j.ejphar.2011.11.051", "22178203"]}, {"Citation": "Su SJ, Yeh YT, Shyu HW. The preventive effect of biochanin a on bone loss in ovariectomized rats: involvement in regulation of growth and activity of osteoblasts and osteoclasts. Evid Based Complement Alternat Med. 2013;2013:594857.", "ArticleIdList": ["PMC3594937", "23533501"]}, {"Citation": "Chundi V, et al. Biochanin-A attenuates neuropathic pain in diabetic rats. J Ayurveda Integr Med. 2016;7(4):231\u2013237. doi: 10.1016/j.jaim.2016.08.001.", "ArticleIdList": ["10.1016/j.jaim.2016.08.001", "PMC5192256", "27890700"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Nguyen NT, et al. Autodock Vina adopts more accurate binding poses but Autodock4 forms better binding Affinity. J Chem Inf Model. 2020;60(1):204\u2013211. doi: 10.1021/acs.jcim.9b00778.", "ArticleIdList": ["10.1021/acs.jcim.9b00778", "31887035"]}, {"Citation": "Zhang J, et al. Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology. Evid Based Complement Alternat Med. 2018;2018:6503126.", "ArticleIdList": ["PMC5944259", "29853965"]}, {"Citation": "Zhang L, et al. Network Pharmacology Approach to uncover the mechanism governing the Effect of Radix Achyranthis Bidentatae on Osteoarthritis. BMC Complement Med Ther. 2020;20(1):121. doi: 10.1186/s12906-020-02909-4.", "ArticleIdList": ["10.1186/s12906-020-02909-4", "PMC7171799", "32316966"]}, {"Citation": "Veber DF, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "Kumar R, et al. New compounds identified through in silico approaches reduce the \u03b1-synuclein expression by inhibiting prolyl oligopeptidase in vitro. Sci Rep. 2017;7(1):10827. doi: 10.1038/s41598-017-11302-0.", "ArticleIdList": ["10.1038/s41598-017-11302-0", "PMC5589771", "28883518"]}, {"Citation": "Rajendran V. Structural analysis of oncogenic mutation of isocitrate dehydrogenase 1. Mol Biosyst. 2016;12(7):2276\u20132287. doi: 10.1039/C6MB00182C.", "ArticleIdList": ["10.1039/C6MB00182C", "27194485"]}, {"Citation": "Rajendran V, Gopalakrishnan C, Sethumadhavan R. Pathological role of a point mutation (T315I) in BCR-ABL1 protein-A computational insight. J Cell Biochem. 2018;119(1):918\u2013925. doi: 10.1002/jcb.26257.", "ArticleIdList": ["10.1002/jcb.26257", "28681927"]}, {"Citation": "Koh WP, et al. Diabetes and risk of hip fracture in the Singapore Chinese Health Study. Diabetes Care. 2010;33(8):1766\u20131770. doi: 10.2337/dc10-0067.", "ArticleIdList": ["10.2337/dc10-0067", "PMC2909059", "20504896"]}, {"Citation": "Qu B, et al. SIRT1 suppresses high glucose and palmitate-induced osteoclast differentiation via deacetylating p66Shc. Mol Cell Endocrinol. 2018;474:97\u2013104. doi: 10.1016/j.mce.2018.02.015.", "ArticleIdList": ["10.1016/j.mce.2018.02.015", "29486220"]}, {"Citation": "Rharass T, Lucas S. High glucose level impairs human mature bone marrow adipocyte function through increased ROS production. Front Endocrinol (Lausanne) 2019;10:607. doi: 10.3389/fendo.2019.00607.", "ArticleIdList": ["10.3389/fendo.2019.00607", "PMC6746912", "31551934"]}, {"Citation": "Sun M, et al. TNF-\u03b1 is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose. Cytokine. 2016;80:35\u201342. doi: 10.1016/j.cyto.2016.01.011.", "ArticleIdList": ["10.1016/j.cyto.2016.01.011", "26945994"]}, {"Citation": "Moonishaa TM, et al. Evaluation of Leptin as a marker of insulin resistance in type 2 Diabetes Mellitus. Int J Appl Basic Med Res. 2017;7(3):176\u2013180. doi: 10.4103/ijabmr.IJABMR_278_16.", "ArticleIdList": ["10.4103/ijabmr.IJABMR_278_16", "PMC5590380", "28904917"]}, {"Citation": "Ahmed QU, et al. Medicinal potential of isoflavonoids: Polyphenols that May cure Diabetes. Molecules. 2020;25(23):5491. doi: 10.3390/molecules25235491.", "ArticleIdList": ["10.3390/molecules25235491", "PMC7727648", "33255206"]}, {"Citation": "Oza MJ, Kulkarni YA. Biochanin A attenuates cardiomyopathy in type 2 Diabetic rats by increasing SIRT1 expression and reducing oxidative stress. Chem Biodivers. 2022;19(3):e202100591. doi: 10.1002/cbdv.202100591.", "ArticleIdList": ["10.1002/cbdv.202100591", "35119190"]}, {"Citation": "Yang J, et al. Gegen Qinlian Decoction ameliorates type 2 Diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array. Phytomedicine. 2022;94:153810. doi: 10.1016/j.phymed.2021.153810.", "ArticleIdList": ["10.1016/j.phymed.2021.153810", "34798519"]}, {"Citation": "He Q, et al. Sanhuang Jiangtang tablet protects type 2 Diabetes osteoporosis via AKT-GSK3\u03b2-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation. J Ethnopharmacol. 2021;273:113946. doi: 10.1016/j.jep.2021.113946.", "ArticleIdList": ["10.1016/j.jep.2021.113946", "33647426"]}, {"Citation": "Napoli N, et al. Mechanisms of Diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208\u2013219. doi: 10.1038/nrendo.2016.153.", "ArticleIdList": ["10.1038/nrendo.2016.153", "27658727"]}, {"Citation": "Agidigbi TS, Kim C. Reactive oxygen species in Osteoclast differentiation and possible Pharmaceutical targets of ROS-Mediated Osteoclast Diseases. Int J Mol Sci. 2019;20(14):3576. doi: 10.3390/ijms20143576.", "ArticleIdList": ["10.3390/ijms20143576", "PMC6678498", "31336616"]}, {"Citation": "Tao H, et al. ROS signaling cascades: dual regulations for osteoclast and osteoblast. Acta Biochim Biophys Sin (Shanghai) 2020;52(10):1055\u20131062. doi: 10.1093/abbs/gmaa098.", "ArticleIdList": ["10.1093/abbs/gmaa098", "33085739"]}, {"Citation": "Kamata H, et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 2005;120(5):649\u2013661. doi: 10.1016/j.cell.2004.12.041.", "ArticleIdList": ["10.1016/j.cell.2004.12.041", "15766528"]}, {"Citation": "Wei ZF, et al. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-\u03baB/c-Fos/NFATc1 Pathways. PLoS ONE. 2013;8(3):e59171. doi: 10.1371/journal.pone.0059171.", "ArticleIdList": ["10.1371/journal.pone.0059171", "PMC3594163", "23536866"]}, {"Citation": "Park JH, Lee NK, Lee SY. Current understanding of RANK Signaling in Osteoclast differentiation and maturation. Mol Cells. 2017;40(10):706\u2013713. doi: 10.14348/molcells.2017.0225.", "ArticleIdList": ["10.14348/molcells.2017.0225", "PMC5682248", "29047262"]}, {"Citation": "Wong BR, et al. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem. 1998;273(43):28355\u201328359. doi: 10.1074/jbc.273.43.28355.", "ArticleIdList": ["10.1074/jbc.273.43.28355", "9774460"]}, {"Citation": "Chiou WF, Huang YL, Liu YW. TRAF6 is poly-ubiquitinated after RANKL stimulation and RANKL-induced expression of NFATc1 in osteoclast differentiation is dependent on TRAF6. 2014."}, {"Citation": "Matsuo K, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004;279(25):26475\u201326480. doi: 10.1074/jbc.M313973200.", "ArticleIdList": ["10.1074/jbc.M313973200", "15073183"]}, {"Citation": "Lee ZH, Kim HH. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003;305(2):211\u2013214. doi: 10.1016/S0006-291X(03)00695-8.", "ArticleIdList": ["10.1016/S0006-291X(03)00695-8", "12745060"]}, {"Citation": "Asagiri M, et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 2005;202(9):1261\u20131269. doi: 10.1084/jem.20051150.", "ArticleIdList": ["10.1084/jem.20051150", "PMC2213228", "16275763"]}, {"Citation": "Balkan W, et al. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Gene. 2009;446(2):90\u201398. doi: 10.1016/j.gene.2009.06.013.", "ArticleIdList": ["10.1016/j.gene.2009.06.013", "19563866"]}, {"Citation": "Shen Z, et al. A novel promoter regulates calcitonin receptor gene expression in human osteoclasts. Biochim Biophys Acta. 2007;1769(11\u201312):659\u2013667. doi: 10.1016/j.bbaexp.2007.08.005.", "ArticleIdList": ["10.1016/j.bbaexp.2007.08.005", "17949830"]}]}], "History": [{"Year": "2023", "Month": "2", "Day": "28"}, {"Year": "2023", "Month": "12", "Day": "27"}, {"Year": "2024", "Month": "1", "Day": "10", "Hour": "6", "Minute": "41"}, {"Year": "2024", "Month": "1", "Day": "9", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "8", "Hour": "23", "Minute": "40"}, {"Year": "2024", "Month": "1", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["38191438", "PMC10773052", "10.1186/s12906-023-04332-x", "10.1186/s12906-023-04332-x"]}}]}